Lucknow: Bollywood singer Kanika Kapoor who stepped into a massive controversy after being found Covid-19 positive on March 20 expressed her desire to donate her plasma for treating Coronavirus patients.


The singer was harshly criticized for her reckless behavior after returning from abroad. She came under attack for negligence and not practicing self-quarantine despite returning to the country from UK amid the Coronavirus pandemic.

According to reports, Kanika on Monday approached Lucknow's King George's Medical University (KGMU) offering to donate her plasma for treatment of other Covid-19 patients.


Tulika Chandra, Head of Department of Transfusion Medicine, KGMU while talking to PTI said, "Singer Kanika Kapoor on Monday expressed her desire to KGMU doctors to donate plasma. After this, she was called and her blood sample was taken for testing. If everything is found appropriate in the report (of the blood test), she will be called on Monday evening or Tuesday to donate her plasma".

She said, "So far, three COVID-19 patients, who have recovered from the infection at the KGMU, have donated their plasma. This includes a resident doctor of KGMU Tauseef Khan, a female doctor from Canada (who was admitted here) and another patient".

A hospital official informed meanwhile, a 58-year-old doctor became the first coronavirus patient at the KGMU here to receive plasma therapy as an experimental treatment for the disease on Monday.

The doctor from Orai in Uttar Pradesh was administered the plasma donated by the woman doctor from Canada who was the first COVID-19 patient admitted to the KGMU and later recovered, Chandra said.


Recently, Uttar Pradesh Chief Minister Yogi Adityanath had asked the state's medical authorities to promote plasma therapy for the treatment of COVID-19 patients after examining its efficacy.

Also, the Indian Council of Medical Research (ICMR) has allowed states to start clinical trials of plasma therapy.

Multiple states like Kerala, Gujarat, and Punjab have already started using it for the treatment of COVID-19 patients. Countries like the United Kingdom and the United States have also commenced plasma therapy trials.